SIP 1.55% $1.31 sigma pharmaceuticals limited

new ceo..?, page-2

  1. 532 Posts.
    lightbulb Created with Sketch. 52
    he worked for Symbion health with deep understanding of there financial's there, perhaps there is some strategic fit between the two and possibly a third company? Due diligence may have shown that the company was worth a lot more than offered, if it is to be sold why would he come back, only to find another job in 12 - 18 months? I think you would have to take it as a positive, although how positive remains to be answered.

    cheers
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.